Phio Pharmaceuticals Corp... (PHIO)
NASDAQ: PHIO
· Real-Time Price · USD
2.21
0.02 (0.91%)
At close: Aug 15, 2025, 3:59 PM
2.12
-4.07%
After-hours: Aug 15, 2025, 07:34 PM EDT
Phio Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.77M | -1.63M | -1.52M | -1.85M | -2.15M | -1.9M | -2.78M | -2.55M | -3.6M | -2.73M | -3.58M | -2.53M | -2.64M | -3.45M | -3.74M | -2.69M | -3.41M |
Depreciation & Amortization | n/a | 42K | -42K | 1K | 34K | 43K | 47K | 47K | 47K | 137K | 15K | 19K | 22K | 20K | 19K | 18K | 18K |
Stock-Based Compensation | 43K | 48K | 52K | 15K | 32K | 9K | 89K | 94K | 111K | 42K | 103K | 83K | 186K | 138K | 143K | 132K | 67K |
Other Working Capital | n/a | 147K | 730K | 38K | 411K | -1.14M | 212K | -102K | -123K | -298K | 506K | -849K | -1.11M | 831K | 711K | -480K | 373K |
Other Non-Cash Items | n/a | -9K | -425K | 15K | 440K | -263K | 651K | 18K | 82K | -91K | 31K | 30K | 30K | 30K | 29K | 29K | 29K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 389K | -651K | -18K | -82K | n/a | n/a | n/a | n/a | n/a | -233K | n/a | n/a |
Change in Working Capital | n/a | 216K | 579K | 38K | 74K | -653K | -256K | -363K | 736K | -62K | -99K | -30K | -1.06M | 792K | 685K | -747K | 260K |
Operating Cash Flow | -1.27M | -1.37M | -1.36M | -1.78M | -2.01M | -2.37M | -2.9M | -2.77M | -2.71M | -2.71M | -3.53M | -2.43M | -3.47M | -2.47M | -3.1M | -3.25M | -3.03M |
Capital Expenditures | -2K | -1K | n/a | n/a | n/a | n/a | n/a | -5K | n/a | -114K | -7K | -10K | -104K | n/a | -30K | -15K | -6K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 9K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -2K | 8K | n/a | n/a | n/a | n/a | n/a | -5K | n/a | -114K | -7K | -10K | -104K | n/a | -30K | -15K | -6K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | -4K | n/a | n/a | n/a | -13K | n/a | -3K | n/a | -25K | -1K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.68M | -1K | n/a | n/a | -4K | -1K | n/a | n/a | -25K | 2K | -3K | n/a | -25K | -1K | 233K | n/a | 21.49M |
Financial Cash Flow | 9.17M | 1.35M | 2.65M | n/a | -4K | 2.4M | n/a | 5.05M | -38K | 2K | -3K | n/a | -25K | -1K | 233K | n/a | 21.49M |
Net Cash Flow | 7.9M | -8K | 692K | -1.78M | -2.02M | 33K | -2.9M | 2.27M | -2.75M | -2.7M | -3.54M | -2.44M | -3.6M | -2.47M | -2.9M | -3.27M | 18.45M |
Free Cash Flow | -1.28M | -1.37M | -1.36M | -1.78M | -2.01M | -2.37M | -2.9M | -2.78M | -2.71M | -2.82M | -3.53M | -2.44M | -3.57M | -2.47M | -3.13M | -3.27M | -3.04M |